期刊文献+

地氯雷他定联合复方甘草酸苷治疗慢性荨麻疹疗效观察 被引量:13

Effect observation of desloratadine combined compound glycyrrhizin in treatment of chronic urticaria
原文传递
导出
摘要 目的观察地氯雷他定片联合复方甘草酸苷片治疗慢性荨麻疹疗效和安全性。方法随机把确诊的慢性荨麻疹194例患者分为两组,以地氯雷他定片联合复方甘草酸苷片为治疗组,共98例;以地雷他定片与马来酸氯苯那敏片联合为对照组,共96例。共治疗8周。在治疗结束时、停药6周后进行随访并进行疗效评价。结果 98例治疗组治疗结束时随访总有效率82.65%,对照组总有效率66.67%(χ2=6.565,P=0.010),有效率比较有统计学意义;停药后6周随访总有效率94.02%,对照组有效率总80.30%(χ2=5.975,P=0.015),有效率比较有统计学意义(P<0.05)。无明显不良反应。结论地氯雷他定片联合复方甘草酸苷片治疗慢性荨麻疹安全疗效好,复发病例少。 Objective To observe the clinical effect and security of desloratadine combined with compound glycyrrhizin in the treatment of chronic urticaria.Methods One hundred and ninety-six patients were randomly divided into treatment group(98 cases)and control group(96 cases).The treatment group were treated with desloratadine and compound glycyrrhizin.The control group were desloratadine and Chlorpheniramine.The effect was evaluated after 8 weeks treatment and 6 weeks drug withdrawal.Results After 8 weeks treatment,the total efficiency of the treatment group(98 cases) was 82.65%,and the control group was 66.67%.There were obvious difference and statistical significance(χ2=6.565,P=0.010).After 6 weeks drug withdrawal,the total efficiency of the treatment group was 94.02%,and the control group was 80.30%.There were obviously difference and statistical significance(χ2=5.975,P=0.015).The two groups had no obvious adverse reaction.Conclusions Desloratadine combined with compound glycyrrhizin therapy is effective and safe,and lower recurrence number.
出处 《医药论坛杂志》 2011年第7期53-55,共3页 Journal of Medical Forum
关键词 荨麻疹 慢性 地氯雷他定 复方甘草酸苷 Urticaria Chronic Desloratadine Compound glycyrrhizin
  • 相关文献

参考文献13

二级参考文献47

  • 1陈玲,南克俊,张晓战.化疗后美能对肝脏功能损害的逆转[J].第四军医大学学报,2004,25(12):1105-1105. 被引量:8
  • 2金永南,徐高中,吕中法.卡介菌多糖核酸联合咪唑斯汀治疗慢性荨麻疹疗效观察[J].中国皮肤性病学杂志,2005,19(6):382-383. 被引量:31
  • 3孙建方,胡兹嘉,刘训荃,周展超,林敏乐,钱恒林,杨雪源,吴晓初.仙特敏治疗38例荨麻疹临床疗效观察[J].中华皮肤科杂志,1995,28(2):130-131. 被引量:52
  • 4任同洲,张石革,李海贝,何木兰.西替利嗪治疗荨麻疹等皮肤病的临床疗效评价[J].中国临床药理学杂志,1996,12(3):148-152. 被引量:18
  • 5Gillard M,Van der Perren C,Massingham R,et al.Binding characteristics of [3H]levocetirizine to cloned human H1-histamine-receptors expressed in CHO cells.Inflamm Res,2002,51 Suppl 1:S77-S78.
  • 6Devalia JL,De Vos C,Hanotte F,et al.A randomized,doubleblind,crossover comparison among cetirizine,levocetirizine,and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.Allergy,2001,56:50-57.
  • 7Wang DY,Hanotte F,De Vos C,et al.Effect of cetirizine,levocetirizine,and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers.Allergy,2001,56:339-343.
  • 8Clough GF,Boutsiouki P,Church MK.et al.Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal,flare,and itch in human skin.Allergy,2001,56:985-988.
  • 9Thomson L,Blaylock MG,Sexton DW,et al.Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells.Clin Exp Allergy,2002,32:1187-1192.
  • 10Leynadier F,Mees K,Arendt C,et al.Efficacy and safety of levocetirizine in seasonal allergic rhinitis.Acta Otorhinolaryngnl Belg,2001,55:305-312.

共引文献293

同被引文献95

引证文献13

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部